HYPERKALEMIA
Clinical trials for HYPERKALEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERKALEMIA trials appear
Sign up with your email to follow new studies for HYPERKALEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lower insulin dose may be just as effective for high potassium
Disease control CompletedThis study tested whether 5 units of insulin works as well as 10 units for lowering dangerously high potassium levels in adults. 384 participants received either dose, and their potassium was measured after 2 hours. The goal was to see if the lower dose could be just as effective…
Matched conditions: HYPERKALEMIA
Phase: PHASE4 • Sponsor: Oman Medical Speciality Board • Aim: Disease control
Last updated May 17, 2026 10:40 UTC
-
Which treatment works best for dangerous potassium levels? large trial reveals answers
Disease control CompletedThis study tested three emergency treatments for dangerously high potassium levels (hyperkalemia) in 419 adults at emergency departments. It compared insulin/dextrose infusion, nebulized salbutamol, and a combination of both to see which lowers potassium most effectively within 6…
Matched conditions: HYPERKALEMIA
Phase: PHASE4 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Potassium binder may unlock lifesaving heart drugs for kidney patients
Disease control CompletedThis study tested whether a drug called Lokelma (SZC) can help people with both chronic kidney disease and heart failure safely reach higher doses of standard heart medications (RAAS inhibitors) that are often limited by high potassium levels. 112 adults with stable kidney diseas…
Matched conditions: HYPERKALEMIA
Phase: PHASE3 • Sponsor: St George's, University of London • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New drug patiromer safely lowers dangerous potassium levels in chinese kidney patients
Disease control CompletedThis study tested a drug called patiromer in 262 Chinese adults with chronic kidney disease and high potassium levels (hyperkalemia). The goal was to see if patiromer could safely lower potassium and allow patients to continue important heart-protective medications. Participants …
Matched conditions: HYPERKALEMIA
Phase: PHASE3 • Sponsor: Vifor Fresenius Medical Care Renal Pharma • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Nurse teaching cuts heart risk for dialysis patients
Disease control CompletedThis study tested if a nurse-led nutrition education program could help dialysis patients lower high potassium levels, a major heart risk. Thirty adults on hemodialysis in Morocco, where dietitians are scarce, took part. After 12 weeks, more patients reached safe potassium levels…
Matched conditions: HYPERKALEMIA
Phase: NA • Sponsor: HASSAN 1st university • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Wearable ECG could spot silent killer in kidney patients
Knowledge-focused CompletedThis study tested whether a small, wearable ECG device can detect high potassium levels (hyperkalemia) in people on dialysis. Thirty-two adults with chronic kidney disease wore the sensor during dialysis sessions over six weeks. Researchers compared ECG readings with blood test r…
Matched conditions: HYPERKALEMIA
Sponsor: Kyungho Park • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC